Consolidated Statements of Income (Loss) - USD ($) shares in Millions, $ in Millions	3 Months Ended	9 Months Ended
Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017
Net revenues	$ 4,529	$ 5,617	$ 14,295	$ 16,987
Cost of sales	2,508	2,967	7,865	8,643
Gross profit	2,021	2,650	6,430	8,344
Research and development expenses	311	531	918	1,432
Selling and marketing expenses	743	843	2,224	2,745
General and administrative expenses	309	372	954	1,101
Other asset impairments, restructuring and other items	658	550	2,080	1,209
Goodwill impairment			300	6,100
Legal settlements and loss contingencies	19	(20)	(1,239)	324
Other income	(35)	(4)	(334)	(100)
Operating income (loss)	16	378	1,527	(4,467)
Financial expenses, net	229	259	736	704
Income (loss) before income taxes	(213)	119	791	(5,171)
Tax benefits	(26)	(494)	(56)	(462)
Share in losses of associated companies, net	10	3	76	10
Net income (loss)	(197)	610	771	(4,719)
Net income attributable to non-controlling interests	11	15	35	11
Net income (loss) attributable to Teva	(208)	595	736	(4,730)
Dividends on preferred shares	65	65	195	195
Net income (loss) attributable to ordinary shareholders	$ (273)	$ 530	$ 541	$ (4,925)
Earnings (loss) per share attributable to ordinary shareholders:
Basic	$ (0.27)	$ 0.52	$ 0.53	$ (4.85)
Diluted	$ (0.27)	$ 0.52	$ 0.53	$ (4.85)
Weighted average number of shares (in millions):
Basic	1,018	1,017	1,018	1,016
Diluted	1,018	1,017	1,020	1,016

Impairments restructuring and others.

No definition available.

Name:	teva_ImpairmentsRestructuringAndOthers
Namespace Prefix:	teva_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

The net proceeds or assets obtained in excess of (less than) the net carrying amount of assets recorded, or assets distributed and liabilities assumed less than (in excess of) litigation reserves extinguished, in settlement of a litigation matter. Represents (for other than an insurance entity in its normal claims settlement process), the amount of income (expense) recognized in the period to settle pending or threatened litigation and insurance claims and the aggregate amount provided for estimated restructuring charges, remediation costs, and asset impairment loss during an accounting period. Generally, these items are either unusual or infrequent, but not both (in which case they would be extraordinary items).

+ References

No definition available.